Resilience Evaluation of Caregivers During the SARS-CoV2 Epidemic Period : Prospective Cohort.

Psychological Clinical Trial

— Resi-CoV  

Official title:

Resilience Evaluation of Caregivers During the SARS-CoV2 Epidemic Period

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04349163
• Other study ID #: 2020-A00831-39
• Status: Completed
• Start date: May 10, 2020
• Est. completion date: June 25, 2020

Study information

• Verified date: May 2020
• Source: University Hospital, Angers
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The outbreak linked to SARS-CoV-2 infection was declared a Public Health Emergency of International Concern on 30 January 2020. In all of the emergency Departments, a major reorganization was necessary, notably with the creation of a specific channel for COVID-19 suspect patients. Thus, all caregivers involved must adapt day by day to new places of exercise, new protocols,...The major influx of patients, the precautions to be taken, the specifics of the pathology and its management have profoundly changed daily practice. This exogenous hospital tension impacts all caregivers and more particularly their resilience capacities. Resilience is defined as an ability to recover from or adjust easily to misfortune or change. The Resi-CoV study aims to assess the level of resilience of caregivers of different specialties and trades in the context of covid-19.

Description:

Caregivers will be invited to complete a self-administered questionnaire online via a personalized electronic message. Caregivers will be free to participate. Signed consent will not be requested, but the return of the questionnaire will be considered consent. The questionnaire will be administered using Google form® software. Caregivers will have 2 weeks to respond. A reminder will be made at 7 days. The questionnaire will be anonymized upon receipt by the investigator.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 280
• Est. completion date: June 25, 2020
• Est. primary completion date: June 15, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Caregivers (physicians, nurses)

• working in the Emergency Department, Anaesthesiology, Infectious Department, Intensive care Unit.

• Voluntary to answer the questionnaire

Exclusion Criteria:

• Working in another Department

Related Conditions & MeSH terms

• Psychological

Intervention

Other:
• Questionnaire
CD-RISC 25 questionnaire

Locations

Country	Name	City	State
France	CHU	Angers

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Angers

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	compare the level of resilience between physicians and caregivers of different specialties and in different workplaces according to the covid-19 epidemic.	CD-RISC-25 : Connor-Davidson Resilience Scale - 25. This scale contain 25 questions each range from 1 to 5. The total is 100 points which means a very high level of resilience.	14 days